Home - POCTRN
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
Our goal is to develop technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.
Our Centers
Atlanta Center for Microsystems Engineered Point-of-Care Technologies
Focus: To develop and translate microsystems-engineered technologies including microchip-enabled devices that include microelectromechanical systems (MEMs)-based sensors, microfluidics, and smartphone-based systems.
Meer lezenOverAtlanta Center for Microsystems Engineered Point-of-Care Technologies »
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
Focus: To develop and test the accuracy, acceptability, and optimal implementation of point-of-care tests for sexually transmitted diseases in diverse care delivery contexts both in the United States and in resource-limited settings.
Meer lezenOverCenter for Point-of-Care Technologies Research for Sexually Transmitted Diseases »
Center for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern
Focus: To support the development of a pipeline of Point-of-Care Technologies designed to meet the clinical needs of people who live with HIV/AIDS in low- and middle-income countries.
Meer lezenOverCenter for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern »
Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases
Focus: To support development and testing of promising “late-stage” point of care technologies that can be rapidly deployed to enhance the diagnosis, monitoring, management and/or treatment of heart, lung, blood and sleep disorders.
Meer lezenOverCenter for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases »
Contentverzamelaar
NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA
Ellume USA’s rapid at-home test was developed through the NIH RADx Initiative.
Meer lezenOverNIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA »
WhenToTest.org
The COVD19 Testing Impact Calculator
Meer lezenOverWhenToTest.org »
In the News
-
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
-
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
- The National Strategy From the COVID-19 Response and Pandemic Preparedness
- Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced
- The Need for More and Better Testing for COVID-19